METHYL (11.BETA.,16.ALPHA.)-9-FLUORO-11-HYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-3,20-DIOXOPREGNA-1,4-DIEN-21-OATE
UNII B9LRJ7MKA2
Substance Identification & Data
This profile provides standardized clinical and technical data for Methyl (11.beta.,16.alpha.)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-3,20-dioxopregna-1,4-dien-21-oate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B9LRJ7MKA2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 53962-32-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H31FO7 MDMRGBNICACKDW-SBDPADKDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Methyl (11.beta.,16.alpha.)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-3,20-dioxopregna-1,4-dien-21-oate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.